Market Trends of Blood Collection Industry
Needles and Syringes are Expected to Hold a Significant Market Share
- Blood collection needles and syringes are poised to experience significant growth in the market due to a surge in surgical procedures, an increase in injury cases, and the launch of new products. Additionally, the prevalence of various infectious diseases has resulted in a rise in demand for blood specimen collection for diagnosis, thereby boosting the demand for needles and syringes for blood collection.
- For example, a study published in the MDPI Journal in February 2021 highlighted that a syringe with a needle is a common open blood collection system. As such, syringes are considered an indispensable part of any phlebotomist's blood-collection device toolkit, thereby driving the segment's growth over the forecast period.
- Furthermore, the rise in surgical cases necessitates various syringes and needles for conducting surgery. As per the February 2023 update by Federal Statistical Office (Destatis), in 2021, around 237,000 women gave birth by cesarean section in Germany. This means that almost every third birth in a hospital in Germany was by cesarean section. The national rate of cesarean sections in 2021 was 30.9%, a slight increase from 2020 (29.7%). Over the last three decades, the proportion of these surgical interventions has doubled. Since Cesarean sections in hospitals require various types of needles, hospitals are likely to utilize needles and syringes, thereby driving the market growth over the forecast period.
- Moreover, advancements in blood collection needles and their launches are expected to fuel market growth. For instance, in May 2022, Dutch medical robotics company Vitestro unveiled an advanced autonomous blood-drawing device. The venipuncture device empowers patients to be self-efficacious during blood collection procedures.
- As a result, due to the increase in surgical procedures and the rise in product launches coupled with advancements, the studied segment is anticipated to drive market growth over the forecast period.
Understand The Key Trends Shaping This Market
Download Sample
North America Anticipated to Hold a Significant Market Share Over the Forecast Period
- North America is anticipated to dominate the studied market over the forecast period, primarily due to several factors, including the rising demand for blood collection products, increased injuries, and a growing prevalence of chronic diseases requiring regular blood sample collection. The market growth is expected to be further fueled by the surge in diabetes prevalence and the corresponding rise in healthcare spending.
- For instance, the International Diabetes Federation Diabetes Atlas Tenth edition reported that 32.2 million individuals in the United States had diabetes in 2021, and this figure is projected to increase to 36.3 million by 2045. Similarly, according to the Diabetes Canada 2022 report, approximately 5,719,000 people in Canada have been diagnosed with diabetes, and this number is anticipated to reach 7,277,000 by 2032. The routine blood drawing required for monitoring blood sugar levels in diabetic patients is expected to drive market growth.
- Moreover, the implementation of various strategies by key market players in the region is anticipated to contribute to market growth. For instance, Ethos Laboratories, a College of American Pathologists-accredited and certified leader in diagnostic testing services, launched Tru-Immune, a finger prick, self-collection kit for its COVID-19 neutralizing antibody test in December 2021. Additionally, in February 2022, BD (Becton, Dickinson, and Company) released UltraSafe Plus 2.25 mL, a new needle-guard solution that enhances the delivery of drugs and other biologic solutions.
- Furthermore, the increase in surgical procedures, which typically require blood collection, is expected to drive market growth. For example, according to the National Institute of Statistics and Geography Health Statistics report published in 2021, 313,104 cesarean sections were performed in private health establishments, accounting for 24.0% of surgical medical procedures in Mexico in 2021.
- The report also indicated that in 2021, 28,361 salpingoclasis were performed as a definitive method of family planning through surgical procedures, equivalent to 2.2% of all surgical interventions. Additionally, 0.2% of surgical vasectomy medical procedures were performed, with 2,893 cases. Consequently, the rise in surgical procedures in the region is expected to lead to an increased demand for blood collection.
- In summary, the growth of the North American blood collection market is anticipated to be driven by an increase in surgical procedures and the prevalence of chronic diseases, such as diabetes, along with the implementation of various strategies by key market players in the region.
Get Analysis on Important Geographic Markets
Download Sample
